183 related articles for article (PubMed ID: 34922559)
1. Integrative multi-omics identifies high risk multiple myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathways.
Ortiz-Estévez M; Towfic F; Flynt E; Stong N; Jang IS; Wang K; Trotter MWB; Thakurta A
BMC Med Genomics; 2021 Dec; 14(1):295. PubMed ID: 34922559
[TBL] [Abstract][Full Text] [Related]
2. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis.
Walker BA; Mavrommatis K; Wardell CP; Ashby TC; Bauer M; Davies F; Rosenthal A; Wang H; Qu P; Hoering A; Samur M; Towfic F; Ortiz M; Flynt E; Yu Z; Yang Z; Rozelle D; Obenauer J; Trotter M; Auclair D; Keats J; Bolli N; Fulciniti M; Szalat R; Moreau P; Durie B; Stewart AK; Goldschmidt H; Raab MS; Einsele H; Sonneveld P; San Miguel J; Lonial S; Jackson GH; Anderson KC; Avet-Loiseau H; Munshi N; Thakurta A; Morgan G
Leukemia; 2019 Jan; 33(1):159-170. PubMed ID: 29967379
[TBL] [Abstract][Full Text] [Related]
3. The Role of DNA Repair in Genomic Instability of Multiple Myeloma.
Ali JYH; Fitieh AM; Ismail IH
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628498
[TBL] [Abstract][Full Text] [Related]
4. Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.
Laganà A; Perumal D; Melnekoff D; Readhead B; Kidd BA; Leshchenko V; Kuo PY; Keats J; DeRome M; Yesil J; Auclair D; Lonial S; Chari A; Cho HJ; Barlogie B; Jagannath S; Dudley JT; Parekh S
Leukemia; 2018 Jan; 32(1):120-130. PubMed ID: 28642592
[TBL] [Abstract][Full Text] [Related]
5. A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy.
Kassambara A; Gourzones-Dmitriev C; Sahota S; Rème T; Moreaux J; Goldschmidt H; Constantinou A; Pasero P; Hose D; Klein B
Oncotarget; 2014 May; 5(9):2487-98. PubMed ID: 24809299
[TBL] [Abstract][Full Text] [Related]
6. The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma.
Choudhury SR; Ashby C; Tytarenko R; Bauer M; Wang Y; Deshpande S; Den J; Schinke C; Zangari M; Thanendrarajan S; Davies FE; van Rhee F; Morgan GJ; Walker BA
J Hematol Oncol; 2020 Aug; 13(1):108. PubMed ID: 32762714
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group.
Samur MK; Aktas Samur A; Fulciniti M; Szalat R; Han T; Shammas M; Richardson P; Magrangeas F; Minvielle S; Corre J; Moreau P; Thakurta A; Anderson KC; Parmigiani G; Avet-Loiseau H; Munshi NC
J Clin Oncol; 2020 Sep; 38(27):3107-3118. PubMed ID: 32687451
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional landscape of DNA repair genes underpins a pan-cancer prognostic signature associated with cell cycle dysregulation and tumor hypoxia.
Chang WH; Lai AG
DNA Repair (Amst); 2019 Jun; 78():142-153. PubMed ID: 31054516
[TBL] [Abstract][Full Text] [Related]
9. Preferential in vivo DNA repair of melphalan-induced damage in human genes is greatly affected by the local chromatin structure.
Souliotis VL; Dimopoulos MA; Episkopou HG; Kyrtopoulos SA; Sfikakis PP
DNA Repair (Amst); 2006 Aug; 5(8):972-85. PubMed ID: 16781199
[TBL] [Abstract][Full Text] [Related]
10. Prognosis, Biology, and Targeting of
Flynt E; Bisht K; Sridharan V; Ortiz M; Towfic F; Thakurta A
Cells; 2020 Jan; 9(2):. PubMed ID: 31991614
[TBL] [Abstract][Full Text] [Related]
11. An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells.
Sousa MM; Zub KA; Aas PA; Hanssen-Bauer A; Demirovic A; Sarno A; Tian E; Liabakk NB; Slupphaug G
PLoS One; 2013; 8(2):e55493. PubMed ID: 23405159
[TBL] [Abstract][Full Text] [Related]
12. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
Wu X; Gu J; Grossman HB; Amos CI; Etzel C; Huang M; Zhang Q; Millikan RE; Lerner S; Dinney CP; Spitz MR
Am J Hum Genet; 2006 Mar; 78(3):464-79. PubMed ID: 16465622
[TBL] [Abstract][Full Text] [Related]
13. Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair.
López-Iglesias AA; Herrero AB; Chesi M; San-Segundo L; González-Méndez L; Hernández-García S; Misiewicz-Krzeminska I; Quwaider D; Martín-Sánchez M; Primo D; Paíno T; Bergsagel PL; Mehrling T; González-Díaz M; San-Miguel JF; Mateos MV; Gutiérrez NC; Garayoa M; Ocio EM
J Hematol Oncol; 2017 Jun; 10(1):127. PubMed ID: 28633670
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in DNA repair pathways are not associated with disease progression among multiple myeloma patients.
Thyagarajan B; Arora M; Guan W; Barcelo H; Jackson S; Kumar S; Gertz M
Leuk Res; 2013 Nov; 37(11):1527-31. PubMed ID: 24129343
[TBL] [Abstract][Full Text] [Related]
15. Cancer Target Gene Screening: a web application for breast cancer target gene screening using multi-omics data analysis.
Kim HY; Choi HJ; Lee JY; Kong G
Brief Bioinform; 2020 Mar; 21(2):663-675. PubMed ID: 30698638
[TBL] [Abstract][Full Text] [Related]
16. Extensive loss of cell-cycle and DNA repair genes in an ancient lineage of bipolar budding yeasts.
Steenwyk JL; Opulente DA; Kominek J; Shen XX; Zhou X; Labella AL; Bradley NP; Eichman BF; Čadež N; Libkind D; DeVirgilio J; Hulfachor AB; Kurtzman CP; Hittinger CT; Rokas A
PLoS Biol; 2019 May; 17(5):e3000255. PubMed ID: 31112549
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling defines a high-risk entity of multiple myeloma.
Zhan FH; Barlogie B; John D S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):191-203. PubMed ID: 17478923
[TBL] [Abstract][Full Text] [Related]
18. Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways.
Tessoulin B; Moreau-Aubry A; Descamps G; Gomez-Bougie P; Maïga S; Gaignard A; Chiron D; Ménoret E; Le Gouill S; Moreau P; Amiot M; Pellat-Deceunynck C
J Hematol Oncol; 2018 Dec; 11(1):137. PubMed ID: 30545397
[TBL] [Abstract][Full Text] [Related]
19. Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27Kip1 and an aggressive clinical course in multiple myeloma.
Shaughnessy J
Hematology; 2005; 10 Suppl 1():117-26. PubMed ID: 16188652
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse.
Krzeminski P; Corchete LA; García JL; López-Corral L; Fermiñán E; García EM; Martín AA; Hernández-Rivas JM; García-Sanz R; San Miguel JF; Gutiérrez NC
Oncotarget; 2016 Dec; 7(49):80664-80679. PubMed ID: 27811368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
